Related Experiment Video
Updated: Jun 26, 2026

Endoscopic Injection Sclerotherapy Assisted by Cyanoacrylate and Clips for Gastroesophageal Varices
Published on: June 13, 2025
Additional Hassab's operation for esophagogastric varices in cirrhotic patients with resectable hepatocellular
Hiroyuki Sugo1, Noriko Fujiwara, Jiro Yoshimoto
1Department of Hepatobiliary-Pancreatic Surgery, Juntendo University School of Medicine, 2-1-1 Hongo, Bunkyo-ku, Tokyo, 113-8421, Japan. sugo@med.juntendo.ac.jp
Insights
Adding Hassab's operation to hepatectomy in cirrhotic patients with hepatocellular carcinoma and esophagogastric varices may reduce fatal variceal hemorrhage risk without impacting overall prognosis.
Area of Science:
- Hepatobiliary Surgery
- Gastroenterology
- Surgical Oncology
Background:
- Hepatocellular carcinoma (HCC) in cirrhotic patients often co-exists with esophagogastric varices.
- Hepatectomy is a standard treatment for resectable HCC.
- The management of concomitant varices during hepatectomy presents a surgical challenge.
Purpose of the Study:
- To evaluate the role of Hassab's operation as an adjunct to hepatectomy.
- To assess its impact on outcomes in cirrhotic patients with HCC and esophagogastric varices.
Main Methods:
- A comparative study of 36 cirrhotic patients with HCC and varices.
- 20 patients underwent hepatectomy alone (non-Hassab group).
- 16 patients underwent hepatectomy with Hassab's operation (Hassab group).
Main Results:
- The Hassab group had more severe varices, lower platelets, poorer prothrombin time, and higher portal pressure preoperatively.
- Despite these factors, operative mortality, postoperative course, and long-term prognosis showed no significant differences.
- Crucially, fatal variceal hemorrhage occurred in 25% of the non-Hassab group versus 0% in the Hassab group (p<0.05).
Conclusions:
- Hassab's operation may be a beneficial adjunct to hepatectomy in select patients.
- It appears to reduce the risk of fatal variceal hemorrhage post-hepatectomy.
- Further research may confirm its role in improving safety for HCC resection in cirrhotic patients with varices.
Background/Aims:
The aim of this study was to clarify the role of the additional Hassab's operation to hepatectomy in cirrhotic patients with resectable hepatocellular carcinomas and esophagogastric varices.
Methodology:
Subjects were 36 cirrhotic patients with hepatocellular carcinomas and concomitant esophagogastric varices: 20 underwent hepatectomy alone (non-Hassab group) and 16 underwent hepatectomy with Hassab's operation (Hassab group).
Results:
Patients in the Hassab group had more advanced esophageal varices and the accompanied gastric varices, preoperatively (p<0.01). Both preoperative platelet counts (p<0.01) and prothrombin time (p<0.05) were significantly lower in the Hassab group, and serum albumin level also tended to be worse than those in the non-Hassab group. Portal pressure was significantly higher in the Hassab group (p<0.01). Despite these disadvantages, no significant differences were found in operative mortality, postoperative courses and long-term prognosis between the two groups. Comparing the cause of death, the incidence of the fatal variceal hemorrhage was significantly lower (0%) in the Hassab group than that (25%) in the non-Hassab group (p<0.05).
Conclusions:
This study suggested that additional Hassab's operation to hepatectomy might have reduced the risk of variceal hemorrhage after hepatectomy.
Related Concept Videos
Esophageal Varices-II: Clinical Features and Management
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol abuse, or...
Esophageal Varices-I: Introduction